Showing results (1711-1720 of 3,475) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|August 26, 2026
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy. Part II: CephalosporinsFemke A Elzinga, Kaylee R M Ferrier, Fabian Mulder, et al.Clinical Pharmacokinetics|August 28, 2026
Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple SclerosisTrond Trætteberg Serkland, Anna-Kristina Fredheim Oma, Erik I Hallin, et al.Clinical Pharmacokinetics|September 16, 2026
Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with TuberculosisYuan J Petermann, Bibie Said, Margaretha L Sariko, et al.Clinical Pharmacokinetics|September 17, 2026
Clinical Pharmacokinetics and Disposition of ImrecoxibShengnan Zhao, Charlie Li, Marlon C Mallillin, et al.Clinical Pharmacokinetics|July 1, 1985
Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapyE W Kraegen, D J ChisholmClinical Pharmacokinetics|June 28, 2022
First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic PropertiesJunichiro James Kazama, Fumihiko Koiwa, Keitaro Yokoyama, et al.Clinical Pharmacokinetics|August 1, 1987
The pharmacokinetics and pharmacodynamics of newer inotropic agentsM L Rocci, H WilsonClinical Pharmacokinetics|October 16, 2020
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug ActionEllen J B Derissen, Jos H BeijnenClinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B DuffullPageof 348